5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile

C57H52BBrN12O6 — CID 165032120

IUPAC5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile
SMILESC.CC(Nc1c(C#N)cnc2ccc(-c3cncc(-c4n[nH]c(=O)o4)c3)cc12)c1ccccc1.CC(Nc1c(C#N)cnc2ccc(B3OC(C)(C)C(C)(C)O3)cc12)c1ccccc1.O=c1[nH]nc(-c2cncc(Br)c2)o1
InChIInChI=1S/C25H18N6O2.C24H26BN3O2.C7H4BrN3O2.CH4/c1-15(16-5-3-2-4-6-16)29-23-20(11-26)14-28-22-8-7-17(10-21(22)23)18-9-19(13-27-12-18)24-30-31-25(32)33-24;1-16(17-9-7-6-8-10-17)28-22-18(14-26)15-27-21-12-11-19(13-20(21)22)25-29-23(2,3)24(4,5)30-25;8-5-1-4(2-9-3-5)6-10-11-7(12)13-6;/h2-10,12-15H,1H3,(H,28,29)(H,31,32);6-13,15-16H,1-5H3,(H,27,28);1-3H,(H,11,12);1H4
InChIKeyMVCFVJZLNLHGEM-UHFFFAOYSA-N
MW1091.84 g/mol
LogP11.09
Rot. Bonds10

About 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile

5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile (PubChem CID 165032120) has the molecular formula C57H52BBrN12O6 and a molecular weight of 1091.84 g/mol. Its IUPAC name is 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile.

Molecular Properties

Compound Name5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile
PubChem CID165032120
Molecular FormulaC57H52BBrN12O6
Molecular Weight1091.84 g/mol
Exact Mass1090.34
IUPAC Name5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile
SMILESC.CC(Nc1c(C#N)cnc2ccc(-c3cncc(-c4n[nH]c(=O)o4)c3)cc12)c1ccccc1.CC(Nc1c(C#N)cnc2ccc(B3OC(C)(C)C(C)(C)O3)cc12)c1ccccc1.O=c1[nH]nc(-c2cncc(Br)c2)o1
InChIInChI=1S/C25H18N6O2.C24H26BN3O2.C7H4BrN3O2.CH4/c1-15(16-5-3-2-4-6-16)29-23-20(11-26)14-28-22-8-7-17(10-21(22)23)18-9-19(13-27-12-18)24-30-31-25(32)33-24;1-16(17-9-7-6-8-10-17)28-22-18(14-26)15-27-21-12-11-19(13-20(21)22)25-29-23(2,3)24(4,5)30-25;8-5-1-4(2-9-3-5)6-10-11-7(12)13-6;/h2-10,12-15H,1H3,(H,28,29)(H,31,32);6-13,15-16H,1-5H3,(H,27,28);1-3H,(H,11,12);1H4
InChIKeyMVCFVJZLNLHGEM-UHFFFAOYSA-N
XLogP11.09
TPSA259.44 Ų
H-Bond Donors4
H-Bond Acceptors16
Rotatable Bonds10
Heavy Atoms77
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001091.84
LogP ≤ 511.09
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile?
The IUPAC name of 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile (CID 165032120) is 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile.
What is the SMILES notation for 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile?
The canonical SMILES for 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile is C.CC(Nc1c(C#N)cnc2ccc(-c3cncc(-c4n[nH]c(=O)o4)c3)cc12)c1ccccc1.CC(Nc1c(C#N)cnc2ccc(B3OC(C)(C)C(C)(C)O3)cc12)c1ccccc1.O=c1[nH]nc(-c2cncc(Br)c2)o1.
What is the InChIKey of 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile?
The InChIKey is MVCFVJZLNLHGEM-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H18N6O2.C24H26BN3O2.C7H4BrN3O2.CH4/c1-15(16-5-3-2-4-6-16)29-23-20(11-26)14-28-22-8-7-17(10-21(22)23)18-9-19(13-27-12-18)24-30-31-25(32)33-24;1-16(17-9-7-6-8-10-17)28-22-18(14-26)15-27-21-12-11-19(13-20(21)22)25-29-23(2,3)24(4,5)30-25;8-5-1-4(2-9-3-5)6-10-11-7(12)13-6;/h2-10,12-15H,1H3,(H,28,29)(H,31,32);6-13,15-16H,1-5H3,(H,27,28);1-3H,(H,11,12);1H4.
What are the key properties of 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile?
5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile has a molecular weight of 1091.84 g/mol, XLogP of 11.09, 10 rotatable bonds, 4 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(5-bromo-3-pyridinyl)-3H-1,3,4-oxadiazol-2-one;methane;6-[5-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-3-pyridinyl]-4-(1-phenylethylamino)quinoline-3-carbonitrile;4-(1-phenylethylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-3-carbonitrile is sourced from PubChem (CID 165032120), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).